Shengda Announces March 2026 Revenue of NT$570 Million, Up 2.8% Year-on-Year
NQ Score
4/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Shengda (stock code: 1720) reported its March 2026 revenue at NT$570.224 million, marking a 2.8% increase compared to the same period last year. This growth in the biotechnology and medical sector highlights the company's steady performance.
AI Analysis
Frequently Asked Questions
- Q: What was Shengda's revenue for March 2026?
- A: Shengda's revenue for March 2026 was 570,224 thousand yuan (0.57 billion yuan).
- Q: What was the year-on-year change in revenue?
- A: It was an increase of +2.8% compared to the same month last year.
- Q: What kind of business does Shengda operate?
- A: Shengda operates in the biotechnology and medical industry, dealing with pharmaceuticals and medical devices.